Browse by Tags

Methadone Rises as a Painkiller With Big Risks - and Cheap Price

The most amazing part of this article is the cost compared to OxyContin, that was an eye opener for me, not being acquainted with pain killing medications. Xanax and Valium do not mix here either and we all remember the Anna Nicole Smith death,...

Published Mon, Aug 08 2008 6:36 PM by The Medical Quack

Filed under: Medically Related, Insurance, Pharma/FDA News, drugs, Physicians, FDA, Pain management, Methadone

The newest generation of drugs: Who can afford them?

This brings up an interesting question, what do you go for relief or bankruptcy? Although now it is not real wide spread, but as the Biomed business continues to grow with new break throughs, how will this process continue? Is this more justification...

Published Mon, Aug 08 2008 4:24 PM by The Medical Quack

Filed under: Medically Related, Insurance, Pharma/FDA News, drugs, health insurance, Generic Drugs, Biomed, Biosimilars, 4 tier

Sanofi-Aventis Sues Apotex Over Taxotere US Patents

The patent is stated not to expire until 2010 and this will put a 30 hold at the FDA to grant approval. This one should prove interesting to follow and see where the infringement occurs. BD LONDON -(Dow Jones)- Sanofi-Aventis SA (SNY) has...

Published Tue, Aug 08 2008 11:34 PM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, drugs, Lawsuit, Pharma, Cancer, FDA, Patents

FDA Warns Consumers About Potential Problems At Two Baltimore Pharmacies - Medicine Shoppe

Hopefully more will come out on this story as to why and how. These are franchise locations, just like the local fast food businesses we visit, thus they are run locally under the terms and agreements of the franchise holder. If they were...

Published Sun, Aug 08 2008 1:27 PM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, drugs, FDA, Pharmacies, Medicine Shoppe

Why Secrecy Still Shrouds FDA Drug Rejections

This brings up some good thoughts here, why not have the FDA be a bit more transparent and issue the letter instead of the company denied. It could certainly ease some of the speculation and guess work in the long run and might even lessen some...

Published Thu, Aug 08 2008 11:38 AM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, drugs, FDA

Kidney patients denied 'too expensive' life-extending drugs - UK

Money is the issue, so will the UK have the worst cancer survival figures in Europe? There still have to be some happy medium whereby drugs are affordable and researchers can still be rewarded. If the drugs never get to the the afflicted patients...

Published Thu, Aug 08 2008 10:47 AM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, drugs, UK, Cancer, cancer research

Drugs for Death, Not Life

Stories like this are sad indeed. It comes back to the dollar and someone playing "God" to determine who gets treatment and who does not. Granted personalized medicine tests will help in time, not only from the actual treatment side...

Published Wed, Aug 08 2008 10:47 AM by The Medical Quack

Filed under: Medically Related, Insurance, drugs, healthcare, health insurance, Prescriptions, Cancer

Maker of Defective Digitek Recalls All Generic Drugs Made at New Jersey Factory

Digitek, as you may or may not remember was found to contain twice the amount of active ingredient in the tablets earlier this year. The list is below as published by the FDA. The recall is being conducted for retailers to return...

Published Tue, Aug 08 2008 12:29 PM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, drugs, Prescriptions, FDA, Generic Drugs, Medications, Recalls

Prescription Data Used To Assess Consumers - No Privacy Unless You Pay Cash...

This brings up one big issue, something I have been aware of for a while, collecting data for one purpose and being used for another, think this doesn't happen, think again. When you sign up for health insurance, you sign you life away for all...

Published Mon, Aug 08 2008 9:36 PM by The Medical Quack

Filed under: Medically Related, Insurance, drugs, health insurance, Prescriptions, Cash

Insurance companies deny coverage based on medications a patient is taking obtained from marketing reports…

One more way for the information to run queries to cherry pick applicants is accomplished. When you apply for insurance, the fine writing will usually state that you are giving permission to check any medical information and records and, yes, this...

Published Fri, Jul 07 2008 5:32 PM by The Medical Quack

Filed under: Medically Related, Insurance, drugs, healthcare, health insurance, Prescriptions, Pharmaceuticals, Medications

Roche Helps Catch Tour de France Cheater

Roche has been all over the news this week and one more claim to fame to their technology was the ability to catch an athlete cheating. Athletes still keep trying but hopefully efforts like this will keep the competition honest and fair, nobody...

Published Wed, Jul 07 2008 2:30 PM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, Other Items of Interest, drugs, Roche, Tour de France

Drug Wars – FDA, Ranbaxy, the Department Of Justice and Congress…

The issues at hand goes back to 2006 with deviations from specifications on drugs, and now it is up to the Congress and the FDA once more. Did the FDA knowingly allow suspected drugs to continue to be sold? Ranbaxy makes a lot of different...

Published Fri, Jul 07 2008 5:14 PM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, drugs, FDA, Congress, Ranbaxy

Liver disease therapeutic patents from CellPoint Diagnostics Up on the Auction Block..

Intellectual Property on the auction block, patents with FDA approval. This is the first time I have noticed technology with health care just up on the open auction block, especially as it relates to cancer research. With the acquisition...

Published Thu, Jul 07 2008 6:10 PM by The Medical Quack

Filed under: Medically Related, Other Items of Interest, Genomics, drugs, Biotech, Research

Drugs industry protecting 'morally unacceptable' patent system

Thomas Pogge, Professor of Philosophy and International Affairs at Yale University in the United States to speak out on reform with the pharmaceutical industry on July 17th in the UK with a new proposal and business model proposition called the Health...

Published Thu, Jul 07 2008 12:38 AM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, drugs, Pharmaceuticals, Patents

As Costs Shift to Patients, Fewer Fill Prescriptions, Maybe…

With the current economic downturn, prescriptions are not necessarily being filled, in other words, patients are not following doctor’s orders. This has another potential issue as well when it comes to pay for performance for physicians too. ...

Published Wed, Jul 07 2008 10:15 AM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, drugs, healthcare, Prescriptions, Economy

Syndication

Recent Posts

Tags

Archives